Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.75 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.75 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL21694093 | 0.99 | CDK1 (0.73) | CDK1CCNB1CA2CA9LDHA | |
| SCHEMBL127859 | 0.99 | CDK1 (0.77) | CDK1CCNB1CA2CA9LDHA | |
| SCHEMBL27892157 | 0.97 | CDK1 (0.75) | CDK1CCNB1CA2CA9LDHA | |
| Water SCHEMBL21694095 | 0.97 | CDK1 (0.75) | CDK1CCNB1CA2CA9LDHA | |
| SCHEMBL2259425 | 0.97 | CDK1 (0.75) | CDK1CCNB1CA2CA9LDHA | |
| SCHEMBL10880542 | 0.97 | CDK1 (0.75) | CDK1CCNB1CA2CA9LDHA | |
| SCHEMBL20769818 | 0.91 | CDK1 (0.77) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL106974 | 0.90 | CDK1 (0.80) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL28123662 | 0.90 | CDK1 (0.80) | CDK1CCNB1CA2CA9LDHA | |
| Sucrose SCHEMBL20769817 | 0.90 | CDK1 (0.80) | CDK1CCNB1CA2CA9LDHA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105764492-B | Pharmaceutical composition comprising phosphate binders particle | 维弗（国际）股份公司 | 2019-09-13 | — | — | CN | disclosed |
| US-20160257958-A1 | Hepcidin Binding Nucleic Acids | NOXXON PHARMA AG (DE) | 2016-09-08 | — | — | US | disclosed |
| US-8841431-B2 | Hepcidin binding nucleic acids | NOXXON PHARMA AG (DE) | 2014-09-23 | — | — | US | disclosed |
| US-20140057970-A1 | Use of Hepcidin Binding Nucleic Acids for Depletion of Hepcidin From the Body | NOXXON PHARMA AG (DE) | 2014-02-27 | — | — | US | disclosed |
| EP-2633053-A1 | USE OF HEPCIDIN BINDING NUCLEIC ACIDS FOR DEPLETION OF HEPCIDIN FROM THE BODY | Noxxon Pharma AG (DE) | 2013-09-04 | — | — | EP | disclosed |
| WO-2012055573-A1 | USE OF HEPCIDIN BINDING NUCLEIC ACIDS FOR DEPLETION OF HEPCIDIN FROM THE BODY | NOXXON PHARMA AG (DE) | 2012-05-03 | — | — | WO | disclosed |
| EP-2424985-A1 | HEPCIDIN BINDING NUCLEIC ACIDS | Noxxon Pharma AG (DE) | 2012-03-07 | — | — | EP | disclosed |
| US-20120053234-A1 | Hepcidin Binding Nucleic Acids | NOXXON PHARMA AG (DE) | 2012-03-01 | — | — | US | disclosed |
| WO-2010124874-A9 | HEPCIDIN BINDING NUCLEIC ACIDS | NOXXON PHARMA AG (DE) | 2011-10-20 | — | — | WO | disclosed |
| WO-2010124874-A1 | HEPCIDIN BINDING NUCLEIC ACIDS | NOXXON PHARMA AG (DE) | 2010-11-04 | — | — | WO | disclosed |